Hangzhou Anchuang Xinrui Biotechnology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Hangzhou Anchuang Xinrui Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include A. The owner is based in Zhejiang Province.
Room 201-5, 2nd Floor, Building 7, Qianwan Bio-Port Phase I, Life Science Innovation Center,
3300 Benjing Avenue, Ningwei Street, Xiaoshan District, Hangzhou City,
Zhejiang Province 311215 , CN
Showing of trademarks Trademarks
Trademark Classifications
Hangzhou Anchuang Xinrui Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Hangzhou Anchuang Xinrui Biotechnology Co., Ltd. have?
Hangzhou Anchuang Xinrui Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Hangzhou Anchuang Xinrui Biotechnology Co., Ltd. file in?
Hangzhou Anchuang Xinrui Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Hangzhou Anchuang Xinrui Biotechnology Co., Ltd.'s most well-known trademarks?
Hangzhou Anchuang Xinrui Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as A. These are among 1 currently registered trademark in the portfolio.
What is Hangzhou Anchuang Xinrui Biotechnology Co., Ltd.'s trademark registration success rate?
Hangzhou Anchuang Xinrui Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.